Free Daily Headlines :

  • COVID-19
  • Money
  • Election 2020
  • Politics
  • Education
  • Health
  • Justice
  • More
    • Environment
    • Economic Development
    • Gaming
    • Investigations
    • Social Services
    • TRANSPORTATION
  • Opinion
    • CT Viewpoints
    • CT Artpoints
DONATE
Reflecting Connecticut’s Reality.
    COVID-19
    Money
    Election 2020
    Politics
    Education
    Health
    Justice
    More
    Environment
    Economic Development
    Gaming
    Investigations
    Social Services
    TRANSPORTATION
    Opinion
    CT Viewpoints
    CT Artpoints

LET�S GET SOCIAL

Show your love for great stories and out standing journalism

GOP, Democrats are miles apart on drug prices

Lawmakers against high drug prices bare partisan teeth

  • Politics
  • by Rachel Bluth | Kaiser Health News
  • March 10, 2019
  • View as "Clean Read" "Exit Clean Read"

While the high cost of prescription drugs seems to be a universally agreed-upon trouble spot in the American health system, a House Ways and Means subcommittee hearing Thursday showed that Democrats and Republicans are still miles apart on what to do about it.

The hearing, focused on using Medicare to encourage affordability, competition and access to medicines, marked the first time since Democrats took control of the House that this panel has dug into a drug pricing issue. It is one of many hearings on the subject in both chambers of Congress this year.

Among the topics in play was legislation introduced in February by Rep. Lloyd Doggett (D-Texas), the health subcommittee’s chair, and Sen. Sherrod Brown (D-Ohio). It would allow Medicare to negotiate for lower drug prices by setting a price for the drug based on a number of market-based factors, such as clinical effectiveness and cost.

If a manufacturer of the brand-name drug doesn’t comply, the government may approve a generic manufacturer to compete with it.

Gage Skidmore / Wikipedia

U.S. Rep. Devin Nunes, R-Calif.

Ranking member Devin Nunes (R-Calif.) dismissed the proposal as “the seizure of medicines by an unhappy government.” Such an approach, he said, was “best left to socialist regimes and not the United States of America.”

“On what planet is this a free market?” asked Rep. Earl Blumenauer (D-Ore.) in regards to drug companies that are guaranteed years without competition when they patent a new drug or device.

Rep. Tom Reed (R-N.Y.) countered: “If there’s no free market, then we’re talking about government takeover of the pharmaceutical industry.”

“Poppycock,” Blumenauer responded.

The Doggett-Brown proposal is based on a concept known as compulsory licensing, which would allow the government to use its power to issue patents as a lever if manufacturers are seen as not operating in good faith.

This approach has some precedent in federal policy. During a national anthrax scare in 2001, when doses of Cipro were needed to combat anthrax, the Department of Health and Human Services leveraged the threat of reissuing patents when the drug manufacturer wouldn’t bring down the prices.

Nunes and other conservative Republicans at the hearing maintained that this government market muscle would discourage research and development of new medicines and treatments, echoing industry representatives who say the strategy is not only costly but also doesn’t always lead to a breakthrough.

“The free market system is the tool that should be used to drive prices down,” Reed said. “That is where the solution lies, rather than taking over this space with some kind of government fiat.” Douglas Holtz-Eakin, president of the conservative American Action Forum and one of the witnesses who testified at the hearing, agreed. “Stripping property rights isn’t the solution,” he said.

Witnesses pointed out several times that the government is already intervening in the market by granting numerous long patents to drug companies and fronting the money for research and development through the National Institutes of Health.

U.S. Rep. Judy Chu. D-Calif.

“All of the new drugs that come to the market have some basis in government funding,” said Ameet Sarpatwari, the assistant director of the program on regulation, therapeutics and law at Harvard Medical School and a panel witness. “There’s a considerable amount of risk the government assumes.”

For some subcommittee Republicans, the sticking point clearly was that allowing Medicare to negotiate drug prices would lead to too much government intervention, and they stuck to that script. “I’m very wary of increased government control,” said Rep. Tom Rice (R-S.C.). “The answer to high drug prices is to move towards more free market and less government control.”

The Ways and Means Committee isn’t the only panel that can influence drug pricing; arguably it’s one of the committees with the least power in this area. Yet the hearing provided a platform to discuss a number of options.

Democrats advanced issues like limiting patents, increasing transparency, trade reform and examining some of the tax breaks for pharmaceutical companies.

Rep. Judy Chu (D-Calif.) questioned the incentives for drug companies to put direct-to-consumer ads on television, which count as business tax deductions. The companies also get tax breaks for donating to patient advocacy groups and donating portions of their inventory.

“It’s pretty safe to say the pharmaceutical industry is doing quite well, that the steady trend of price increases is not creating a lack of revenue,” Chu said. “In fact, there are high salaries, bonuses and many stock buybacks.”

KHN correspondent Shefali Luthra contributed to this report.

This story first appeared March 7, 2019, in Kaiser Health News (KHN), a national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation which is not affiliated with Kaiser Permanente.

Sign up for CT Mirror's free daily news summary.

Free to Read. Not Free to Produce.

The Connecticut Mirror is a nonprofit newsroom. 90% of our revenue comes from people like you. If you value our reporting please consider making a donation. You'll enjoy reading CT Mirror even more knowing you helped make it happen.

YES, I'LL DONATE TODAY

ABOUT THE AUTHOR

Rachel Bluth | Kaiser Health News

SEE WHAT READERS SAID

RELATED STORIES
‘No one took us seriously:’ Black cops warned about racist Capitol Police officers for years
by Joshua Kaplan and Joaquin Sapien | ProPublica

While many officers were filmed fighting off Capitol rioters, at least 12 others are under investigation for possibly assisting them.

Donald Trump built a national debt so big (even before the pandemic) that it’ll weigh down the economy for years
by Allan Sloan and Cezary Podkul | ProPublica

The national debt has risen by almost $7.8 trillion during President Trump’s time in office.

Domestic terrorism: A more urgent threat, but weaker laws
by Sebastian Rotella | ProPublica

The FBI dissuaded some people contemplating violence from showing up in Washington — but couldn't arrest them.

‘This is life in this country.’ D.C. Trump riots echo racial violence throughout U.S. history, CT leaders say
by Kelan Lyons

The chaos unfolding in Washington is a forcible reminder about white privilege in this country, black leaders say.

Connecticut officials react to chaos at U.S. Capitol
by CT Mirror Staff

Elected officials from both parties denounced the rioting in the U.S. Capitol Wednesday.

Support Our Work

Show your love for great stories and outstanding journalism.

$
Select One
  • Monthly
  • Yearly
  • Once
Artpoint painter
CT ViewpointsCT Artpoints
Opinion The change in leadership must not lead to complacency
by Jenna Van Donselaar

We are beginning 2021, and most people are far done with election talk. Sure, the polls are closed, and the results are in, and it is time to move on. I am weary from the hours I spent texting voters this fall, and I’d like to think all my efforts were worth it. But the work is far from done.

Opinion Treason is in the air
by David Holahan

Abraham Lincoln had been elected but had yet to assume the presidency when southern states started seceding from the Union in the months before his March 4, 1961 inauguration. Four others would follow that spring. American soldiers —like Robert E. Lee, who had taken an oath of loyalty to the nation that he had served since 1825— defected to the Confederacy. By joining the rebellion Lee and fellow travellers became, in effect, traitors.

Opinion Trump’s reaction to defeat further confirms urgency for school focus on social emotional skills 
by Sandra M. Chafouleas 

Imagine what would happen if a preschooler didn’t “use their words” when they got upset about sharing, instead stomping around yelling while adults simply observed in silence. Think about what the school climate would feel like if a student punched another during recess while others watched without seeking help.  Now consider the actions – and inactions – by Trump Jan. 6 as the electoral vote counts occurred at the U.S. Capitol.

Opinion Is Trump leading a cult?
by Elena Sada

My experience as a former cult member and researcher in the field of Social Sciences earned me the ability to identify narcissism and cultish tendencies. Furthermore, as a former  New York City resident who kept abreast of interviews with the city’s apparent “movers and shakers,” I often questioned Trump’s qualifications as a leader, let alone as national presidential leader.

Artwork Grand guidance
by Anne:Gogh

In a world of systemic oppression aimed towards those of darker skintones – representation matters. We are more than our equity elusive environments, more than numbers in a prison and much more than victims of societal dispositions. This piece depicts a melanated young man draped in a cape ascending high above multiple forms of oppression. […]

Artwork Shea
by Anthony Valentine

Shea is a story about race and social inequalities that plague America. It is a narrative that prompts the question, “Do you know what it’s like to wake up in new skin?”

Artwork The Declaration of Human Rights
by Andres Chaparro

Through my artwork I strive to create an example of ideas that reflect my desire to raise social consciousness, and cultural awareness. Jazz music is the catalyst to all my work, and plays a major influence in each piece of work.”

Artwork ‘A thing of beauty. Destroy it forever’
by Richard DiCarlo | Derby

During times like these it’s often fun to revisit something familiar and approach things with a different slant. I have been taking some Pop culture and Art masterpieces and applying the vintage 1960’s and 70’s classic figures (Fisher Price, little people) to the make an amusing pieces. Here is my homage to Fisher -Price, Yellow […]

Twitter Feed
A Twitter List by CTMirror

Engage

  • Reflections Tickets & Sponsorships
  • Events
  • Donate
  • Newsletter Sign-Up
  • Submit to Viewpoints
  • Submit to ArtPoints
  • Economic Indicator Dashboard
  • Speaking Engagements
  • Commenting Guidelines
  • Legal Notices
  • Contact Us

About

  • About CT Mirror
  • Announcements
  • Board
  • Staff
  • Sponsors and Funders
  • Donors
  • Friends of CT Mirror
  • History
  • Financial
  • Policies
  • Strategic Plan

Opportunity

  • Advertising and Sponsorship
  • Speaking Engagements
  • Use of Photography
  • Work for Us

Go Deeper

  • Steady Habits Podcast
  • Economic Indicator Dashboard
  • Five Things

The Connecticut News Project, Inc. 1049 Asylum Avenue, Hartford, CT 06105. Phone: 860-218-6380

© Copyright 2021, The Connecticut News Project. All Rights Reserved. Website by Web Publisher PRO